4DX 4DMedical Limited
—Mkt Cap: —P/E: —1d ago
4DMedical Limited operates as a medical technology company in the United States and Australia. The company engages in medical research technology and development of a non invasive respiratory imaging solution. It offers …
Industry Peers
Medical Devices & SuppliesKey Statistics
Company
Market Cap—
Enterprise Value1.63B USD
Revenue (TTM)4.88M USD
Gross Profit4.58M USD
Net Income (TTM)-141.28M USD
Revenue/Share0.01 AUD
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees181
CountryAU
SectorHealthcare
IndustryMedical Devices & Supplies
ISINAU0000095416
Valuation
P/E (Trailing)—
P/E (Forward)-209.23
PEG—
EV/EBITDA-42.07
EV/Revenue333.74
P/S347.84
P/B14.32
EPS (TTM)-0.41
EPS (Forward)-0.02
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin93.77%
Oper. Margin-735.06%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-174.43%
ROA-15.61%
Growth
Revenue Growth42.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-21.61M USD
CapEx (TTM)195.76K USD
FCF Margin-1926.18%
FCF Yield—
Net Debt-67.53M USD
Net Debt/EBITDA1.74
Balance Sheet
Debt/Equity0.07
Current Ratio30.79
Quick Ratio30.52
Book Value/Sh0.28 AUD
Cash/Share0.46 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating3.0 (Hold)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)4.367 AUD
Target Range3.000 AUD – 6.000 AUD
# Analysts3
Ownership
Shares Out.602.03M
Float505.54M
Insiders16.58%
Institutions23.84%
Technical
SMA 503.860 AUD
SMA 2004.124 AUD
Beta1.84
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)3.57M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—